AAAAAA

   
Results: 1-17 |
Results: 17
EXPRESSION AND POSSIBLE IMPLICATIONS OF I MMUNE FUNCTION-ASSOCIATED MOLECULES ON CANCER-CELLS AND LYMPHOCYTES OF MALIGNANT SUBJECTS
Authors: CHAKRAVARTY PK
Citation: Pk. Chakravarty, EXPRESSION AND POSSIBLE IMPLICATIONS OF I MMUNE FUNCTION-ASSOCIATED MOLECULES ON CANCER-CELLS AND LYMPHOCYTES OF MALIGNANT SUBJECTS, Eksperimental'naa onkologia, 18(2), 1996, pp. 158-161
IN-VIVO EFFECT OF CHEMICALLY-INDUCED FIBROSARCOMA ON COPPER-METABOLISM OF LIVER IN MICE
Authors: CHAKRAVARTY PK GHOSH A
Citation: Pk. Chakravarty et A. Ghosh, IN-VIVO EFFECT OF CHEMICALLY-INDUCED FIBROSARCOMA ON COPPER-METABOLISM OF LIVER IN MICE, Neoplasma, 43(4), 1996, pp. 271-274
PHARMACOLOGY OF L-744,453, A NOVEL NONPEPTIDYL ENDOTHELIN ANTAGONIST
Authors: WILLIAMS DL MURPHY KL NOLAN NA OBRIEN JA LIS EV PETTIBONE DJ CLINESCHMIDT BV KRAUSE SM VEBER DF NAYLOR EM CHAKRAVARTY PK WALSH TF DHANOA DM CHEN A BAGLEY SW FITCH KJ GREENLEE WJ
Citation: Dl. Williams et al., PHARMACOLOGY OF L-744,453, A NOVEL NONPEPTIDYL ENDOTHELIN ANTAGONIST, Life sciences, 58(14), 1996, pp. 1149-1157
IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996
Authors: KIVLIGHN SD ZINGARO GJ GABEL RA BROTEN TP SCHORN TW SCHAFFER LW NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996, American journal of hypertension, 8(1), 1995, pp. 58-66
BIOTRANSFORMATION OF LOSARTAN TO ITS ACTIVE CARBOXYLIC-ACID METABOLITE IN HUMAN LIVER-MICROSOMES - ROLE OF CYTOCHROME P4502C AND 3A SUBFAMILY MEMBERS
Authors: STEARNS RA CHAKRAVARTY PK CHEN R CHIU SHL
Citation: Ra. Stearns et al., BIOTRANSFORMATION OF LOSARTAN TO ITS ACTIVE CARBOXYLIC-ACID METABOLITE IN HUMAN LIVER-MICROSOMES - ROLE OF CYTOCHROME P4502C AND 3A SUBFAMILY MEMBERS, Drug metabolism and disposition, 23(2), 1995, pp. 207-215
PHARMACOLOGY OF L-754,142, A HIGHLY POTENT, ORALLY-ACTIVE, NONPEPTIDYL ENDOTHELIN ANTAGONIST
Authors: WILLIAMS DL MURPHY KL NOLAN NA OBRIEN JA PETTIBONE DJ KIVLIGHN SD KRAUSE SM LIS EV ZINGARO GJ GABEL RA CLAYTON FC SIEGL PKS ZHANG K NAUE J VYAS K WALSH TF FITCH KJ CHAKRAVARTY PK GREENLEE WJ CLINESCHMIDT BV
Citation: Dl. Williams et al., PHARMACOLOGY OF L-754,142, A HIGHLY POTENT, ORALLY-ACTIVE, NONPEPTIDYL ENDOTHELIN ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1518-1526
POTENT IMIDAZOLE ANGIOTENSIN-II ANTAGONISTS - ACYL SULFONAMIDES AND ACYL SULFAMIDES AS TETRAZOLE REPLACEMENTS
Authors: NAYLOR EM CHAKRAVARTY PK COSTELLO CA CHANG RS CHEN TB FAUST KA LOTTI VJ KIVLIGHN SD ZINGARO GJ SIEGL PKS WONG PC CARINI DJ WEXLER RR PATCHETT AA GREENLEE WJ
Citation: Em. Naylor et al., POTENT IMIDAZOLE ANGIOTENSIN-II ANTAGONISTS - ACYL SULFONAMIDES AND ACYL SULFAMIDES AS TETRAZOLE REPLACEMENTS, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 69-74
QUINAZOLINONE BIPHENYL ACYLSULFONAMIDES - A POTENT NEW CLASS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS
Authors: CHAKRAVARTY PK STRELITZ RA CHEN TB CHANG RSL LOTTI VJ ZINGARO GJ SCHORN TW KIVLIGHN SD SIEGL PKS PATCHETT AA GREENLEE WJ
Citation: Pk. Chakravarty et al., QUINAZOLINONE BIPHENYL ACYLSULFONAMIDES - A POTENT NEW CLASS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 75-80
TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE
Authors: CHANG LL ASHTON WT FLANAGAN KL NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ BENDESKY RJ CHEN TB FAUST KA KLING PJ SCHAFFER LW SCHORN TW ZINGARO GJ CHANG RSL LOTTI VJ KIVLIGHN SD SIEGL PKS
Citation: Ll. Chang et al., TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 115-120
IN-VIVO PHARMACOLOGY AND ANTIHYPERTENSIVE ACTIVITY OF L-159,282 (MK-996) A NONPEPTIDE ANGIOTENSIN-II (A-II) RECEPTOR ANTAGONIST
Authors: SIEGL PKS GABEL RA ZINGARO GJ SCHORN T HARVEY C ARBEGAST P BROTEN TP SCHAFFER LW CHAKRAVARTY PK GREENLEE W NAVLOR E PATCHETT AA KIVLIGHN SD
Citation: Pks. Siegl et al., IN-VIVO PHARMACOLOGY AND ANTIHYPERTENSIVE ACTIVITY OF L-159,282 (MK-996) A NONPEPTIDE ANGIOTENSIN-II (A-II) RECEPTOR ANTAGONIST, The FASEB journal, 8(5), 1994, pp. 10000881-10000881
A COMPARISON OF ANTIHYPERTENSIVE EFFICACY AND EFFECTS ON RENAL-FUNCTION OF L-159,282 (MK-996) DILTIAZEM AND HYDROCHLOROTHIAZIDE IN THE CONSCIOUS SHR
Authors: GABEL RA KIVLIGHN SD CHAKRAVARTY PK NAYLOR E GREENLEE WJ PATCHETT AA SIEGL PKS
Citation: Ra. Gabel et al., A COMPARISON OF ANTIHYPERTENSIVE EFFICACY AND EFFECTS ON RENAL-FUNCTION OF L-159,282 (MK-996) DILTIAZEM AND HYDROCHLOROTHIAZIDE IN THE CONSCIOUS SHR, The FASEB journal, 8(5), 1994, pp. 10000881-10000881
PLASMA AND ERYTHROCYTE COPPER LEVEL AS AN INDICATOR OF DISEASE-ACTIVITY DURING MALIGNANCY
Authors: CHAKRAVARTY PK GHOSH A CHOWDHURY JR
Citation: Pk. Chakravarty et al., PLASMA AND ERYTHROCYTE COPPER LEVEL AS AN INDICATOR OF DISEASE-ACTIVITY DURING MALIGNANCY, Cancer letters, 84(2), 1994, pp. 177-182
IN-VITRO PHARMACOLOGY OF MK-996, A NEW POTENT AND SELECTIVE ANGIOTENSIN-II (AT(1)) RECEPTOR ANTAGONIST
Authors: CHANG RSL BENDESKY RJ CHEN TB FAUST KA KLING PJ OMALLEY SA NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ CLINESCHMIDT BV LOTTI VJ
Citation: Rsl. Chang et al., IN-VITRO PHARMACOLOGY OF MK-996, A NEW POTENT AND SELECTIVE ANGIOTENSIN-II (AT(1)) RECEPTOR ANTAGONIST, Drug development research, 32(3), 1994, pp. 161-171
EFFECT OF FIBROSARCOMA INDUCTION ON COPPER AND CERULOPLASMIN CONCENTRATION IN DIFFERENT ORGANS OF THE HOST
Authors: CHAKRAVARTY PK GHOSH A CHOWDHURY JR
Citation: Pk. Chakravarty et al., EFFECT OF FIBROSARCOMA INDUCTION ON COPPER AND CERULOPLASMIN CONCENTRATION IN DIFFERENT ORGANS OF THE HOST, Neoplasma, 41(3), 1994, pp. 187-189
A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST
Authors: CHAKRAVARTY PK NAYLOR EM CHEN A CHANG RSL CHEN TB FAUST KA LOTTI VJ KIVLIGHN SD GABLE RA ZINGARO GJ SCHORN TW SCHAFFER LW BROTEN TP SIEGL PKS PATCHETT AA GREENLEE WJ
Citation: Pk. Chakravarty et al., A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 37(24), 1994, pp. 4068-4072
TRIAZOLINONE BIPHENYLSULFONAMIDE DERIVATIVES AS ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONISTS WITH POTENT AT(1) RECEPTOR AFFINITY AND ENHANCED AT(2) AFFINITY
Authors: ASHTON WT CHANG LL FLANAGAN KL HUTCHINS SM NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ CHEN TB FAUST KA CHANG RSL LOTTI VJ ZINGARO GJ SCHORN TW SIEGL PKS KIVLIGHN SD
Citation: Wt. Ashton et al., TRIAZOLINONE BIPHENYLSULFONAMIDE DERIVATIVES AS ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONISTS WITH POTENT AT(1) RECEPTOR AFFINITY AND ENHANCED AT(2) AFFINITY, Journal of medicinal chemistry, 37(17), 1994, pp. 2808-2824
(DIPROPYLPHENOXY)PHENYLACETIC ACIDS - A NEW-GENERATION OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
Authors: DHANOA DS BAGLEY SW CHANG RSL LOTTI VJ CHEN TB KIVLIGHN SD ZINGARO GJ SIEGL PKS CHAKRAVARTY PK PATCHETT AA GREENLEE WJ
Citation: Ds. Dhanoa et al., (DIPROPYLPHENOXY)PHENYLACETIC ACIDS - A NEW-GENERATION OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(23), 1993, pp. 3738-3742
Risultati: 1-17 |